Zeer Transasia Bio-Medicals / intent / transasia-bio-medicals

Transasia Bio-Medicals

1001-5000 employees·Mumbai, India·transasia.co.in

Observed, not inferred · updated weekly

Buying intent

29 tracked signals | Top 15 topics are below | Product and Support are carrying most of it.

18signals · 30 days
26topics tracked
66.67%attributed to a team

Attention by team

LinkedIn activity, by team

Where Transasia Bio-Medicals's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Health Care
Quality Management
Medical Technology
Customer Experience and Engagement
Medical Devices
Customer Relationship Management (CRM)
Product
High25% of team Product to Health Care: High, 25% of this team's signals
High25% of team Product to Quality Management: High, 25% of this team's signals
High25% of team Product to Medical Technology: High, 25% of this team's signals
Product to Customer Experience and Engagement: no signal
High25% of team Product to Medical Devices: High, 25% of this team's signals
Product to Customer Relationship Management (CRM): no signal
Support
Support to Health Care: no signal
Support to Quality Management: no signal
Support to Medical Technology: no signal
High50% of team Support to Customer Experience and Engagement: High, 50% of this team's signals
Support to Medical Devices: no signal
High50% of team Support to Customer Relationship Management (CRM): High, 50% of this team's signals
Others
High33% of team Others to Health Care: High, 33% of this team's signals
High33% of team Others to Quality Management: High, 33% of this team's signals
High33% of team Others to Medical Technology: High, 33% of this team's signals
Others to Customer Experience and Engagement: no signal
Others to Medical Devices: no signal
Others to Customer Relationship Management (CRM): no signal
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Health Care
LinkedIn
High volume
98%
last
29d ago
Quality Management
LinkedIn
High volume
98%
last
14d ago
Medical Technology
LinkedIn
High volume
98%
last
29d ago
Customer Experience and Engagement
LinkedIn
Medium volume
98%
last
18d ago
Medical Devices
LinkedIn
Medium volume
98%
last
29d ago
Customer Relationship Management (CRM)
LinkedIn
Medium volume
98%
last
18d ago
Audit Planning
LinkedIn
Medium volume
98%
last
14d ago
Channel Management
LinkedIn
Medium volume
98%
last
18d ago
Healthcare Providers
LinkedIn
Medium volume
94%
last
7d ago
Patient Care
LinkedIn
Medium volume
98%
last
30d ago
Market Access
LinkedIn
Medium volume
98%
last
29d ago
Service Management
LinkedIn
Medium volume
96%
last
18d ago
Artificial Intelligence
LinkedIn
Medium volume
96%
last
20d ago
Quality Management Software
LinkedIn
Medium volume
92%
last
14d ago
Career Development
LinkedIn
Medium volume
98%
last
7d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Transasia Bio-Medicals

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others3 active
Senior ICresearching Quality Management Software
in
Senior ICresearching Healthcare Professionals
in
Senior ICresearching Patient Care
in
Support1 active
researching Service Management
in
Product1 active
Leadershipresearching Market Access
in
Marketing1 active
Leadershipresearching Artificial Intelligence
in

Primary products / business lines

LinkedIn company profile

Incepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is recognized as India’s Largest In-vitro Diagnostic Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Accurate and quality diagnostics can make all the difference i

Top accounts researching Transasia Bio-Medicals

names withheld on the public page

These are companies whose own people brought up Transasia Bio-Medicals unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

6,524 companies · 23,607 people are researching Health Care

Transasia Bio-Medicals's own team shows 2 signals on this topic. No one outside Transasia Bio-Medicals has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Quality Management2,143 cos · 8,017 people
  • Medical Technology803 cos · 2,489 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Transasia Bio-Medicals.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Marketing — 1 person; Product — 1 person

What's been said

public posts by Transasia Bio-Medicals's team

No public post naming Transasia Bio-Medicals has surfaced in the past year, so this is what Transasia Bio-Medicals's own team is posting about publicly — their topics, in their words.

LinkedInMedical Devices

10 cities. 5 countries. 10 days. Year-ends are for several things: celebration, reflection, gratitude, and setting the tone for new beginnings. For this past year, Erba-Transasia story is simple: Growth is back. And it is real. In FY25-26, INR revenues grew 13% — after three years of flatlining. Entirely organic. India and International, both grew in double digits. EBITDA was up 27%. Margins expanded across geographies. International business — historically in cash losses — has fully turned around. Erba-Transasia 2.0 is about steady execution. Boring, but detailed. Strong governance, KPIs and trackers. Hopefully not micromanagement, but certainly micro tracking. The past two weeks were a blur, meeting employees across India — Mumbai, Siliguri, Goa, Indore, Delhi… and across our international offices in Eastern Europe (our factory is in Czech and Russia, R&D centres in France and Austria, and HQ in Dubai). See pictures. But one thing was starkly clear: the energy of our people. 2,000 colleagues. One shared belief, one zeitgeist: we are building something that matters. Our founder’s vision remains our compass: Build a healthier, happier world. We provide Innovative, Reliable and yet Affordable diagnostic solutions. As a young man, he spent 9 years volunteering — unpaid — with the Moral Rearmament Movement led by Rajmohan Gandhi (Gandhiji's grandson). Purpose before profit. Conviction before comfort. Our ambition is clear: to build a true Indian MNC, amongst Top 20 Global IVD companies — one that makes India self-reliant and proud. If India can be the pharmacy of the world, why not a leader in medical devices too? Affordable. High-quality. Global. Today, 1.4 billion laboratory tests every year run on Erba machines, across 80 countries. Equal to 1 test for every Indian. A dream come true. A quiet number. A powerful impact. Suresh Vazirani Shiraz Bugwadia Dr. Sanjay Arora Rajendra Gandhi

Apr 2026
LinkedIn

Excited to welcome more customers to the NIHON KOHDEN INDIA family! Thank you for trusting our innovative and reliable solutions to advance healthcare and improve patient outcomes. Together, we’re driving excellence in medical technology. #NihonKohden #HealthcareInnovation "

Apr 2026

About this data. Transasia Bio-Medicals (transasia.co.in). Department attribution is 66.67%; remaining activity is grouped under Others. Updated 2026-09-25T18:00:10.181Z.

Not yet computedPer-team narrative summaries